Position in PFE
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$407,722
-$60,989 QoQ
Shares Held
16,932
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#1,898
of 2,821 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MeadowBrook Investment Advisors LLC holds $2,663,207 across 7 Drug Manufacturers - General names. PFE ranks #4 (15.3% of the industry book) .
All Filings in PFE
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $407,722 | 16,932 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $468,711 | 16,692 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $452,109 | 18,157 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $477,036 | 18,722 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $422,915 | 17,447 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $483,031 | 19,062 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $511,020 | 19,262 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $622,759 | 21,519 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $554,647 | 19,823 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $527,666 | 19,015 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $441,724 | 15,343 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||